Also known as: KX-826
Novel topical androgen receptor inhibitor in phase III trials for AGA in China.
Pyrilutamide is a non-steroidal topical androgen receptor (AR) degrader and antagonist developed by Kintor Pharma. It binds to the AR ligand-binding domain, blocking DHT signaling at the follicle. It may also promote AR protein degradation, providing a dual mechanism of androgen blockade.
Unlock Premium Content
Get full access to in-depth analyses, cited studies, premium articles, and AI chat.
$12/mo
View pricing